Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
ABC transporters | R-HSA-1369007 | map02010 | metanephrine | 21100 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | metolazone | 36119 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | metolazone | 36119 | drug-path |
Jak-STAT signaling pathway | R-HSA-168638 | map04630 | metolazone | 36119 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | metolazone | 36119 | drug-path |
B cell receptor signaling pathway | R-HSA-983705 | map04662 | metolazone | 36119 | drug-path |
Notch signaling pathway | R-HSA-157118 | map04330 | metolazone | 36119 | drug-path |
mTOR signaling pathway | R-HSA-165662 | map04150 | metolazone | 36119 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | dipyridamole | 3108 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | dipyridamole | 3108 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | dipyridamole | 3108 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | dipyridamole | 3108 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | dipyridamole | 3108 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | dipyridamole | 3108 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | dipyridamole | 3108 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | dipyridamole | 3108 | drug-path |
ABC transporters | R-HSA-1369007 | map02010 | loxapine | 3964 | drug-path |
Notch signaling pathway | R-HSA-157118 | map04330 | loxapine | 3964 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | propranolol | 4946 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | propranolol | 4946 | drug-path |